Taiyen Biotech マネジメント

Mr. Shi-Hui Chen serves as President at Taiyen Biotech Co., Ltd. since 2021. He served as Vice President of Taiyen Biotech Co., Ltd.He served as Spokesperson of Taiyen Biotech Co., Ltd. He served as Direc...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Shi-Hui Chen	President	3.8yrs	データなし	データなし
Wei Su	Director of Financial Accounting Department	no data	データなし	データなし
An-Ping Ho	Director of Administrative Department & Representative Director	less than a year	データなし	データなし
Tung-Hsuan Yang	Director of Legal Affairs Office	no data	データなし	データなし
Chieh-Han Lee	VP & Director of Corporate Development Department	no data	データなし	0.00089% NT$ 57.8k
Mei-Wen Chen	Director of Branding & Marketing Department	no data	データなし	データなし
Mei-Yu Chuang	Chief Internal Auditor	2yrs	データなし	データなし

2.0yrs

平均在職期間

経験豊富な経営陣: 1737の経営陣は経験豊富であると考えられます ( 2年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
An-Ping Ho	Director of Administrative Department & Representative Director	less than a year	データなし	データなし
Yen-Che Ting	Chairman of the Board	less than a year	データなし	データなし
Hsien-Kuei Liao	Director	no data	データなし	データなし
Kuan-Ping Chen	Director	5.4yrs	データなし	データなし
Chien-Lung Chan	Independent Director	5.4yrs	データなし	データなし
Shun-Tien Huang	Independent Director	5.4yrs	データなし	データなし
Ying-Man Kuo	Independent Director	5.4yrs	データなし	データなし
Shih-Hao Wu	Independent Director	2.3yrs	データなし	データなし
Chia-Ling Lee	Independent Director	2.3yrs	データなし	データなし
Yu-Pen Lin	Independent Director	1.4yrs	データなし	データなし
Wei-I Chu	Representative Director	1.3yrs	データなし	データなし

2.3yrs

平均在職期間

経験豊富なボード: 1737の取締役会は経験豊富ではない ( 2.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Taiyen Biotech マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Taiyen Biotech Co., Ltd. Announces the Appointment of Ting, Yen-Che as Institutional Director

High number of new directors

Taiyen Biotech Co., Ltd. Announces the Appointment of Ho, An-Ping as Institutional Director

Taiyen Biotech Co., Ltd., Annual General Meeting, Jun 21, 2024

High number of new directors

Taiyen Biotech Co., Ltd. Announces Director Changes

Recent updates

Third quarter 2024 earnings released: EPS: NT$0.45 (vs NT$0.76 in 3Q 2023)

Taiyen Biotech Co., Ltd. Announces the Appointment of Ting, Yen-Che as Institutional Director

Upcoming dividend of NT$1.20 per share

Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Dividend reduced to NT$1.20

Taiyen Biotech Co., Ltd. to Report Q2, 2024 Results on Jul 29, 2024

High number of new directors

Taiyen Biotech Co., Ltd. Announces the Appointment of Ho, An-Ping as Institutional Director

Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

First quarter 2024 earnings released: EPS: NT$0.52 (vs NT$0.54 in 1Q 2023)

Full year 2023 earnings released: EPS: NT$1.50 (vs NT$2.13 in FY 2022)

Taiyen Biotech Co., Ltd., Annual General Meeting, Jun 21, 2024

Upcoming dividend of NT$1.50 per share at 4.4% yield

Second quarter 2023 earnings released: EPS: NT$0.19 (vs NT$0.23 in 2Q 2022)

Taiyen Biotech Co., Ltd. Approves Cash Dividend, Payable on September 19, 2023

High number of new directors

Taiyen Biotech Co., Ltd. Announces Director Changes

New major risk - Revenue and earnings growth

Taiyen Greenenergy Co., LTD. Announces Resignation of Yi-Hui Tsai as Director of Financial& Accounting, Effective June 20, 2023

Full year 2022 earnings released: EPS: NT$2.13 (vs NT$1.97 in FY 2021)

Full year 2022 earnings released: EPS: NT$2.13 (vs NT$1.97 in FY 2021)

Taiyen Biotech Co., Ltd. Change of the Spokesperson

Third quarter 2022 earnings released: EPS: NT$0.81 (vs NT$0.50 in 3Q 2021)

Taiyen Biotech Co., Ltd. Replaces Wang, Ching-Sen with Chuang, Mei-Yu as Chief Internal Auditor, with Effect from November 16, 2022

Upcoming dividend of NT$1.50 per share

Second quarter 2022 earnings released: EPS: NT$0.23 (vs NT$0.53 in 2Q 2021)

Taiyen Biotech Co., Ltd. Announces Cash Dividend, Payable on September 20, 2022

Taiyen Biotech Co., Ltd. Announces Executive Changes

First quarter 2022 earnings released: EPS: NT$0.64 (vs NT$0.51 in 1Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: EPS NT$0.50 (vs NT$0.48 in 3Q 2020)

Upcoming dividend of NT$1.35 per share

Second quarter 2021 earnings released: EPS NT$0.53 (vs NT$0.41 in 2Q 2020)

First quarter 2021 earnings released: EPS NT$0.51 (vs NT$0.33 in 1Q 2020)

Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

Full year 2020 earnings released: EPS NT$1.83 (vs NT$1.73 in FY 2019)

A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

New 90-day low: NT$31.85

Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

New 90-day low: NT$32.05

Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Third quarter 2020 earnings released: EPS NT$0.48

New 90-day high: NT$32.70

New 90-day low - NT$30.60

First half earnings released

First half earnings released

New 90-day high - NT$31.95

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

マネジメント基準チェック /14